1. Home
  2. IVVD vs LIVE Comparison

IVVD vs LIVE Comparison

Compare IVVD & LIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • LIVE
  • Stock Information
  • Founded
  • IVVD 2020
  • LIVE 1968
  • Country
  • IVVD United States
  • LIVE United States
  • Employees
  • IVVD N/A
  • LIVE N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • LIVE Other Specialty Stores
  • Sector
  • IVVD Health Care
  • LIVE Consumer Discretionary
  • Exchange
  • IVVD Nasdaq
  • LIVE Nasdaq
  • Market Cap
  • IVVD 63.4M
  • LIVE 54.1M
  • IPO Year
  • IVVD 2021
  • LIVE N/A
  • Fundamental
  • Price
  • IVVD $1.34
  • LIVE $17.19
  • Analyst Decision
  • IVVD Strong Buy
  • LIVE
  • Analyst Count
  • IVVD 4
  • LIVE 0
  • Target Price
  • IVVD $3.64
  • LIVE N/A
  • AVG Volume (30 Days)
  • IVVD 15.0M
  • LIVE 23.3K
  • Earning Date
  • IVVD 11-13-2025
  • LIVE 08-07-2025
  • Dividend Yield
  • IVVD N/A
  • LIVE N/A
  • EPS Growth
  • IVVD N/A
  • LIVE N/A
  • EPS
  • IVVD N/A
  • LIVE 0.46
  • Revenue
  • IVVD $46,210,000.00
  • LIVE $443,794,000.00
  • Revenue This Year
  • IVVD $385.94
  • LIVE N/A
  • Revenue Next Year
  • IVVD $62.62
  • LIVE N/A
  • P/E Ratio
  • IVVD N/A
  • LIVE $38.16
  • Revenue Growth
  • IVVD 1941.08
  • LIVE N/A
  • 52 Week Low
  • IVVD $0.35
  • LIVE $6.25
  • 52 Week High
  • IVVD $2.74
  • LIVE $25.88
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 66.86
  • LIVE 49.33
  • Support Level
  • IVVD $1.05
  • LIVE $14.99
  • Resistance Level
  • IVVD $1.45
  • LIVE $23.00
  • Average True Range (ATR)
  • IVVD 0.19
  • LIVE 1.69
  • MACD
  • IVVD 0.05
  • LIVE -0.24
  • Stochastic Oscillator
  • IVVD 83.82
  • LIVE 27.47

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

Share on Social Networks: